|Bid||39.210 x 1500|
|Ask||39.220 x 1100|
|Day's Range||39.170 - 39.510|
|52 Week Range||37.200 - 44.580|
|PE Ratio (TTM)||44.13|
|Earnings Date||Feb 1, 2017 - Feb 6, 2017|
|Dividend & Yield||1.99 (5.09%)|
|1y Target Est||48.00|
Sir, Joining in the discussion about GlaxoSmithKline's new plans, I find chief executive Emma Walmsley's strategic thinking on research and development questionable. I suggest it shows the terrible consequences ...
The drug would be the first such treatment in Europe.
Barely four months into her tenure as chief executive of GlaxoSmithKline, Emma Walmsley is showing her determination to focus the pharmaceutical company's research and development efforts. Having said ...